Wave Life Sciences WVE
NASDAQ WVE
$4.85 +0.15 (+3.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Wave Life Sciences (WVE) Preferred Shares (2014)

Wave Life Sciences' (WVE) quarterly Preferred Shares came in at $7.9 million in Q4 2014.

Analysis

Wave Life Sciences (WVE) Preferred Shares (2014) Analysis & Trends

Wave Life Sciences (WVE) has 1 years of Preferred Shares data on file, last reported at $7.9 million in Q4 2014.

  • Quarterly Preferred Shares changed N/A year-over-year to $7.9 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $7.9 million (changed N/A YoY) and the FY2014 annual result came in at $7.9 million, changed N/A from the prior year.
  • Preferred Shares was little changed at $7.9 million in Q4 2014.
  • In the past five years, Preferred Shares ranged from a high of $7.9 million in Q4 2014 to a low of $7.9 million in Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Wave Life Sciences 994.54 Mn 626.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 7.87 Mn